Erweka (India) Private Limited logo

Erweka (India) Private Limited

Manufacturer and supplier of pharmaceutical and analytical equipments, also provides services and spares.
2001 | Ahmedabad, Gujarat (India) | Active

Last Updated:

December 19, 2024
HomeCompanyErweka (India) Private Limited

Who are the key members and board of directors at Erweka (India)?

Board Members(3)

NameDesignationAppointment DateStatus
Shantanu Dharmadhikari In Director 10-Apr-2019Current
Sonal Shah In Director 19-Dec-2001Current
Sandeep Shah In Director 02-Aug-2001Current

Financial Performance of Erweka (India).

Erweka (India) Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 7.95% increase. The company also saw a substantial improvement in profitability, with a 24% increase in profit. The company's net worth Soared by an impressive increase of 16.38%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
7.95%
Revenue from Operations
10.64%
Total Assets
21.64%
Profit or Loss
24.00%
Net Worth
16.38%
EBITDA
49.27%

Related Corporates (Common Directorship)

Charges (Loans)

Satisfied Charges

₹25.00 M

LenderAmountStatus

Tata Capital Financial Services Limited

Creation Date: 23 Dec 2022
₹2.50 CrSatisfied

How Many Employees Work at Erweka (India)?

Unlock and access historical data on people associated with Erweka (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Erweka (India)

Recent activity within the organization

  • Annual General Meeting

    Erweka (India) Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Erweka (India) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

    31 Mar 2024

  • Charges

    A charge registered on 23 Dec 2022 via Charge ID 100663269 with Tata Capital Financial Services Limited was fully satisfied on 01 Dec 2023.

    01 Dec 2023

  • Charges

    A charge with Tata Capital Financial Services Limited of Rs. 25.00 M registered on 23 Dec 2022 with Charge ID 100663269 was modified on 09 Jan 2023.

    09 Jan 2023

  • Charges

    A charge with Tata Capital Financial Services Limited amounted to Rs. 25.00 M with Charge ID 100663269 was registered on 23 Dec 2022.

    23 Dec 2022

  • Director Appointment

    Shantanu Dharmadhikari was appointed as a Director was appointed as a Director on 10 Apr 2019 & has been associated with this company since 5 years 9 months .

    10 Apr 2019

Frequently asked questions

  • Erweka (India) Private Limited was incorporated on 02 Aug 2001.

  • The authorized share capital of Erweka (India) Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.

  • Currently 3 directors are associated with Erweka (India) Private Limited.

    • Sonal Sandeep Shah
    • Sandeep Jagjivan Shah
    • Shantanu Dharmadhikari
  • As per Ministry of Corporate Affairs (Mca), the registered address of Erweka (India) Private Limited is 401 Ashirwad Paras Opp. Krishna Bunglow Nr. Prahlad Nagar Garden Corporate Road, Pr Ahladnagar India, Ahmedabad, Gujarat, 380015.

  • The corporate identification number (CIN) of Erweka (India) Private Limited is U29297GJ2001PTC039841 and the company number is 039841 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Erweka (India) Private Limited is https://www.erwekaindia.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Erweka (India) Private Limited has risen by 7.95%.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Erweka (India) Private Limited has experienced an upsurge of 16.38%.

  • The most recent Balance Sheet for Erweka (India) Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development